Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study

Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study

Bibliographic Details
Main Authors:	Estébanez, Miriam, Stella-Ascariz, Natalia, Mingorance, Jesús, Pérez-Valero, Ignacio, Bernardino, Jose Ignacio, Zamora, Francisco Xavier, Montes, Maria Luisa, González-García, Juan Julián, Arribas, José Ramón
Format:	Online
Language:	English
Published:	BioMed Central 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097047/

Similar Items

Neurocognitive Impairment in Patients Treated with Protease Inhibitor Monotherapy or Triple Drug Antiretroviral Therapy
by: Pérez-Valero, Ignacio, et al.
Published: (2013)

Cerebral volumes, neuronal integrity and brain inflammation measured by MRI in patients receiving PI monotherapy or triple therapy
by: Pérez Valero, Ignacio, et al.
Published: (2014)

Long-Term Control of Human Immunodeficiency Virus-1 Replication Despite Extensive Resistance to Current Antiretroviral Regimens: Clonal Analysis of Resistance Mutations in Proviral Deoxyribonucleic Acid
by: Stella-Ascariz, Natalia, et al.
Published: (2016)

Facial emotional processing deficits in long-term HIV-suppressed patients
by: Gonzalez-Baeza, Alicia, et al.
Published: (2014)

Boosted protease inhibitor monotherapy in HIV-infected adults: outputs from a pan-European expert panel meeting
by: Arribas, José R, et al.
Published: (2013)

Clinical significance of procoagulant microparticles
by: Nomura, Shosaku, et al.
Published: (2015)

Efficacy of PI monotherapy versus triple therapy for 1964 patients in 10 randomised trials
by: Arribas, Jose, et al.
Published: (2014)

Cost-effectiveness analysis of protease inhibitor monotherapy vs. ongoing triple-therapy in the long-term management of HIV patients
by: Oddershede, Lars, et al.
Published: (2014)

Naïve patients receiving TDF/FTC-EFV as 2 pills are more likely to modify regimen components than patients receiving a TDF/FTC/EFV single pill
by: Perez-Valero, I, et al.
Published: (2010)

The state of PI monotherapy and NRTI-sparing therapy
by: Arribas, JR
Published: (2010)

Bocavirus viremia
by: Sukkaromdee, Pathoom, et al.
Published: (2015)

No Differences of Immune Activation and Microbial Translocation Among HIV-infected Children Receiving Combined Antiretroviral Therapy or Protease Inhibitor Monotherapy
by: Falcon-Neyra, Lola, et al.
Published: (2015)

Procoagulant inhibitory properties of paclitaxel poliglumex
by: Nemunaitis, John, et al.
Published: (2010)

Procoagulant and Anticoagulant Factors in Childhood Hypothyroidism
by: Kilic, Nevin, et al.
Published: (2012)

Resistance mutations in protease gene at baseline are not related to virological failure in patients treated with darunavir/ritonavir monotherapy
by: Gutierrez-Liarte, Angela, et al.
Published: (2014)

Effectiveness of Protease Inhibitor Monotherapy versus Combination Antiretroviral Maintenance Therapy: A Meta-Analysis
by: Mathis, Sandra, et al.
Published: (2011)

Differential Effects of Viremia and Microbial Translocation on Immune Activation in HIV-Infected Patients Throughout Ritonavir-Boosted Darunavir Monotherapy
by: BenMarzouk-Hidalgo, Omar J., et al.
Published: (2015)

The MONET trial: correlation between Hepatitis C coinfection and HIV RNA responses during darunavir/ritonavir monotherapy, for patients with HIV RNA <50 copies/mL at baseline
by: Arribas, Jose R, et al.
Published: (2010)

Design of small-molecule active-site inhibitors of the S1A family proteases as procoagulant and anticoagulant drugs
by: Fischer, Peter M.
Published: (2017)

Origin and Diversification of Meprin Proteases
by: Marín, Ignacio
Published: (2015)

Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens
by: López-Cortés, Luis F., et al.
Published: (2016)

VIREMIA IN HUMAN POLIOMYELITIS
by: Horstmann, Dorothy M., et al.
Published: (1954)

Self-regulation of procoagulant events on the endothelial cell surface
Published: (1985)

Lymphocyte cooperation is required for amplification of macrophage procoagulant activity
Published: (1980)

Procoagulant activity and thrombelastography in Korean hemorrhagic fever.
by: Lee, M., et al.
Published: (1986)

The procoagulant effects of fine particulate matter in vivo
by: Kilinç, Evren, et al.
Published: (2011)

Structural Requirements for the Procoagulant Activity of Nucleic Acids
by: Gansler, Julia, et al.
Published: (2012)

Modeling and Simulation of Procoagulant Circulating Tumor Cells in Flow
by: Lee, Angela M., et al.
Published: (2012)

Elevated Levels of Procoagulant Plasma Microvesicles in Dialysis Patients
by: Burton, James O., et al.
Published: (2013)

Procoagulant Microparticles in Dogs with Immune‐Mediated Hemolytic Anemia
by: Kidd, L., et al.
Published: (2015)

Simple clotting test to detect procoagulant abdominal swabs
by: Krajewski, Stefanie, et al.
Published: (2015)

Low level HIV viremia is more frequent under protease-inhibitor containing firstline therapy than under NNRTI-regimens
by: Wiesmann, Frank, et al.
Published: (2014)

Rotavirus Antigenemia in Children Is Associated with Viremia
by: Blutt, Sarah E, et al.
Published: (2007)

Cytomegalovirus Viremia, Pneumonitis, and Tocilizumab Therapy
by: van Duin, David, et al.
Published: (2011)

Residual Viremia in Treated HIV+ Individuals
by: Conway, Jessica M., et al.
Published: (2016)

Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East Africa
by: Sutherland, Katherine A., et al.
Published: (2015)

Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial
by: Sutherland, Katherine A., et al.
Published: (2015)

Pott's disease and hypercalcemia in a patient with rheumatoid arthritis receiving methotrexate monotherapy
by: Zorlu, Mehmet, et al.
Published: (2013)

Residual Viremia Is Preceding Viral Blips and Persistent Low-Level Viremia in Treated HIV-1 Patients
by: Hofstra, Laura Marije, et al.
Published: (2014)

Osteotomías de reorientación acetabular. Estudio comparativo entre osteotomía triple y osteotomía periacetabular. [Periacetabular reorientation osteotomies. Comparative study between triple pelvic osteotomy and periacetabular osteotomy].
by: Sebastian Falcinelli, et al.
Published: (2017-02-01)